Feasibility trial for adjuvant chemotherapy with docetaxel plus cisplatin followed by single agent long-term administration of S-1 chemotherapy in patients with completely resected non-small cell lung cancer: Thoracic Oncology Research Group Study 0809

BACKGROUND: We conducted a multicentre feasibility study for single agent long-term S-1 chemotherapy following docetaxel plus cisplatin in patients with curatively resected stage II–IIIA non-small cell lung cancer. METHODS: Patients received three cycles of docetaxel (60 mg m(−2)) plus cisplatin (80...

Descripción completa

Detalles Bibliográficos
Autores principales: Niho, S, Ikeda, N, Michimae, H, Suzuki, K, Sakai, H, Kaburagi, T, Minato, K, Kato, T, Okamoto, H, Seto, T, Hosomi, Y, Shimizu, K, Oshita, F, Kunitoh, H, Tsuboi, M, Takeuchi, M, Watanabe, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738148/
https://www.ncbi.nlm.nih.gov/pubmed/23868010
http://dx.doi.org/10.1038/bjc.2013.378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738148/
https://www.ncbi.nlm.nih.gov/pubmed/23868010
http://dx.doi.org/10.1038/bjc.2013.378

Ejemplares similares